Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment

References

• Gossop M, Stewart D, Treacy S, et al. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97:39–47.
   PubMed Web of Science ®Google Scholar
• Darke S, Mills KL, Ross J, et al. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug Alcohol Depend. 2011;115:190–195.
   PubMed Web of Science ®Google Scholar
• Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98:1169–1171.
   PubMed Web of Science ®Google Scholar
• Roxburgh A, Darke S, Salmon AM, et al. Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre. Drug Alcohol Depend. 2017;176:126–132.
   PubMed Web of Science ®Google Scholar
• Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011;39:545–558.
   PubMed Web of Science ®Google Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112:226–238.
   PubMed Web of Science ®Google Scholar
• Strang J. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110: 27–35.
   PubMed Web of Science ®Google Scholar
• Jolley CJ, Bell J, Rafferty GF, et al. Understanding heroin overdose: a study of the acute respiratory depressant effects of injected pharmaceutical heroin. PLoS One. 2015;10:e0140995.
   PubMed Web of Science ®Google Scholar
• Dursteler-Mac Farland KM, Stormer R, Seifritz E, et al. Opioid-associated effects on oxygen saturation. Addiction. 2000;95:285–287.
   PubMed Web of Science ®Google Scholar
• Stoermer R, Drewe J, Dursteler-MacFarland KM, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry. 2003;54:854–861.
   PubMed Web of Science ®Google Scholar
• Kaufman RD, Gabathuler ML, Bellville JW. Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration. J Pharmacol Exp Ther. 1981;219:156–162.
   PubMed Web of Science ®Google Scholar
• van Dorp E, Yassen A, Dahan A. Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf. 2007;6:125–132.
   PubMed Web of Science ®Google Scholar
• Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
   PubMed Web of Science ®Google Scholar
• Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. EMJ. 2005;22:612–616.
   Web of Science ®Google Scholar
• Etherington J, Christenson J, Innes G, et al. Is early discharge safe after naloxone reversal of presumed opioid overdose? CJEM. 2000;2:156–162.
   PubMedGoogle Scholar
• Smith DA, Leake L, Loflin JR, et al. Is admission after intravenous heroin overdose necessary? Ann Emerg Med. 1992;21:1326–1330.
   PubMed Web of Science ®Google Scholar
• Willman MW, Liss DB, Schwarz ES, et al. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2017;55:81–87.
   PubMed Web of Science ®Google Scholar
• Cantwell K, Dietze P, Flander L. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting. Resuscitation. 2005;65:315–319.
   PubMed Web of Science ®Google Scholar
• Rudolph SS, Jehu G, Nielsen SL, et al. Prehospital treatment of opioid overdose in Copenhagen-is it safe to discharge on-scene? Resuscitation. 2011;82:1414–1418.
   PubMed Web of Science ®Google Scholar
• Vilke GM, Buchanan J, Dunford JV, et al. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3:183–186.
   Google Scholar
• Vilke GM, Sloane C, Smith AM, et al. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med. 2003;10:893–896.
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina DK, McManus J, et al. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15:320–324.
   Google Scholar
• Boyd JJ, Kuisma MJ, Alaspaa AO, et al. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients. Acta Anaesthesiol Scand. 2006;50:1266–1270.
   PubMed Web of Science ®Google Scholar
• Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660–667.
   PubMed Web of Science ®Google Scholar
• Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20:566–569.
   Google Scholar
• Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142:101–113.
   PubMed Web of Science ®Google Scholar
• Jones AW, Holmgren A, Ahlner J. Concentrations of free-morphine in peripheral blood after recent use of heroin in overdose deaths and in apprehended drivers. Forensic Sci Int. 2012;215:18–24.
   PubMed Web of Science ®Google Scholar
• Jones AW, Holmgren A. Concentration ratios of free-morphine to free-codeine in femoral blood in heroin-related poisoning deaths. Leg Med (Tokyo). 2011;13:171–173.
   PubMed Web of Science ®Google Scholar
• Konstantinova SV, Normann PT, Arnestad M, et al. Morphine to codeine concentration ratio in blood and urine as a marker of illicit heroin use in forensic autopsy samples. Forensic Sci Int. 2012;217:216–221.
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Torok M. The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug Alcohol Depend. 2010;106:1–6.
   PubMed Web of Science ®Google Scholar
• Drummer OH. Post-mortem toxicology. Forensic Sci Int. 2007;165:199–203.
   PubMed Web of Science ®Google Scholar
• Mertz KJ, Janssen JK, Williams KE. Underrepresentation of heroin involvement in unintentional drug overdose deaths in Allegheny County, PA. J Forensic Sci. 2014;59:1583–1585.
   PubMed Web of Science ®Google Scholar
• Ruhm CJ. Drug poisoning deaths in the United States, 1999-2012: a statistical adjustment analysis. Popul Health Metr. 2016;14:2.
   PubMed Web of Science ®Google Scholar
• Lloyd B, Matthews S, Gao XC, Trends in alcohol and drug related ambulance attendances in Victoria: 2012/13. Fitzroy, VIC: Turning Point; 2014.
   Google Scholar
• Rook EJ, van Ree JM, van den Brink W, et al. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol. 2006;98:86–96.
   PubMed Web of Science ®Google Scholar
• Rook EJ, Huitema AD, van den Brink W, et al. Population pharmacokinetics of heroin and its major metabolites. Clin Pharmacokinet. 2006;45:401–417.
   PubMed Web of Science ®Google Scholar
• Dubois N, Demaret I, Ansseau M, et al. Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the “chasing the dragon” route in severe heroin addicts. Acta Clin Belg. 2013;68:359–367.
   PubMed Web of Science ®Google Scholar
• Gottas A, Oiestad EL, Boix F, et al. Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats. Br J Pharmacol. 2013;170:546–556.
   PubMed Web of Science ®Google Scholar
• Gerostamoulos D, Beyer J, Staikos V, et al. The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens. Forensic Sci Med Pathol. 2012;8:373–379.
   PubMed Web of Science ®Google Scholar
• Hoiseth G, Fjeld B, Burns ML, et al. Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at −20 °C. Forensic Sci Int. 2014;239:6–10.
   PubMed Web of Science ®Google Scholar
• Papoutsis I, Nikolaou P, Pistos C, et al. Stability of morphine, codeine, and 6-acetylmorphine in blood at different sampling and storage conditions. J Forensic Sci. 2014;59:550–554.
   PubMed Web of Science ®Google Scholar
• Stam NC, Gerostamoulos D, Dietze PM, et al. The attribution of a death to heroin: a model to help improve the consistent and transparent classification and reporting of heroin-related deaths. Forensic Sci Int. 2017;281:18–28.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32–51.
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, et al. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24:425–432.
   PubMed Web of Science ®Google Scholar
• White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961–972.
   PubMed Web of Science ®Google Scholar
• Warner-Smith M, Darke S, Lynskey M, et al. Heroin overdose: causes and consequences. Addiction. 2001;96:1113–1125.
   PubMed Web of Science ®Google Scholar
• Palmer RB. Fentanyl in postmortem forensic toxicology. Clin Toxicol (Phila). 2010;48:771–784.
   PubMed Web of Science ®Google Scholar
• Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376:605–607.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• Shoff EN, Zaney ME, Kahl JH, et al. Qualitative identification of fentanyl analogs and other opioids in postmortem cases by UHPLC-Ion Trap-MSn. J Anal Toxicol. 2017;41:484–492.
   PubMed Web of Science ®Google Scholar
• Prekupec MP, Mansky PA, Baumann MH. Misuse of novel synthetic opioids: a deadly new trend. J Addict Med. 2017;11:256–265.
   PubMed Web of Science ®Google Scholar
• Siddiqi S, Verney C, Dargan P, et al. Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clin Toxicol (Phila). 2015;53:54–59.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Pasternak GW. Novel synthetic opioids and overdose deaths: Tip of the iceberg? Neuropsychopharmacology. 2018;43:216–217.
   PubMed Web of Science ®Google Scholar
• Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–116.
   PubMed Web of Science ®Google Scholar
• Schumann H, Erickson T, Thompson TM, et al. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol (Phila). 2008;46:501–506.
   PubMed Web of Science ®Google Scholar
• Sutter ME, Gerona RR, Davis MT, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017;24:106–113.
   PubMed Web of Science ®Google Scholar